Full Text
Full text is available in PDF
Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Comparison of Intra-Arterial Chemotherapy with Gemcitabine or Floxuridine Followed by TACE with Oxaliplatine
Author(s):
Hao Ming Zhi1, 
Chen Qiang2,*, Lin Hai Lan1, Wu Hui3, Chen Qi Zhong3, Li Jian Cheng3, Zheng Jian Xiong3, Ye Yun Bin31Department of Interventional Radiology, Fujian Provincial Tumor Hospital, Fujian, P.R.China
2Department of Medical Oncology, Fujian Provincial Tumor Hospital, [email protected], Fujian Province, P.R.China
3Department of Medical Oncology, Fujian Provincial Tumor Hospital, Fujian Province, P.R.China
Published online:Dec 31, 2009
Article type:Research Article
Received:Jul 30, 2009
Accepted:Oct 12, 2009
How to Cite:Zhi H, Qiang C, Lan L, Hui W, Zhong C, et al. Comparison of Intra-Arterial Chemotherapy with Gemcitabine or Floxuridine Followed by TACE with Oxaliplatine. Hepat Mon. 2009;9(4):. doi:
Abstract
Copyright
© 2009, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
16
Jan
2017
Hepatic Arterial Infusion Chemotherapy with Cisplatin for TACE-Refractory or -Ineligible Hepatocellular Carcinoma with Child-Pugh Score of 8 or Above
Michihisa Moriguchi,
Takeshi Aramaki,
Kiichiro Yoza,
Kenji Iwai,
Rui Sato,
Koiku Asakura
,et al.Moriguchi M, Aramaki T, Yoza K, Iwai K, Sato R, et al. Hepatic Arterial Infusion Chemotherapy with Cisplatin for TACE-Refractory or -Ineligible Hepatocellular Carcinoma with Child-Pugh Score of 8 or Above. Hepat Mon. 2017;17(2):e43627. doi: https://doi.org/10.5812/hepatmon.43627
16
Jul
2025
Prophylactic Interventional Therapy After Hepatectomy for Primary Liver Cancer: A Clinical Comparative Study of FOLFOX-HAIC and TACE
Shuai He,
Wenjie Lou,
Junwei Zhao,
Yuxing Ni,
Haijun Du,
Xiyuan Yang
He S, Lou W, Zhao J, Ni Y, Du H, et al. Prophylactic Interventional Therapy After Hepatectomy for Primary Liver Cancer: A Clinical Comparative Study of FOLFOX-HAIC and TACE. Hepat Mon. 2025;25(1):e160901. doi: https://doi.org/10.5812/hepatmon-160901
23
Feb
2026
Efficacy and Safety Analysis of Local-Systemic Combined Therapy Versus Systemic Therapy Alone in TACE-Resistant Hepatocellular Carcinoma Patients
Peijie Xia,
Aibing Xu,
Siyuan Tian,
Honghua Huang,
Miao Ouyang,
Shengnan Huang
,et al.Xia P, Xu A, Tian S, Huang H, Ouyang M, et al. Efficacy and Safety Analysis of Local-Systemic Combined Therapy Versus Systemic Therapy Alone in TACE-Resistant Hepatocellular Carcinoma Patients. Hepat Mon. 2026;26(1):e168214. doi: https://doi.org/10.5812/hepatmon-168214
24
May
2023
Transarterial Chemoembolization for Refractory Hepatocellular Carcinoma Following Anti-angiogenic Therapy Combined with Immune Checkpoint Inhibitors: A Retrospective Single-center Analysis
Qimin Zhang,
Jiajia Xu,
Mengye Xiong,
Yiqing Tan
Zhang Q, Xu J, Xiong M, Tan Y. Transarterial Chemoembolization for Refractory Hepatocellular Carcinoma Following Anti-angiogenic Therapy Combined with Immune Checkpoint Inhibitors: A Retrospective Single-center Analysis. I J Radiol. 2023;20(2):e133070. doi: https://doi.org/10.5812/iranjradiol-133070
28
Dec
2014
Transcatheter Arterial Chemoembolization Therapy for Patients With Unresectable Hepatocellular Carcinoma
Kavous Firouznia,
Hossein Ghanaati,
Seyed Moayed Alavian,
Payam Azadeh,
Mohsen Nasiri Toosi,
Arya Haj Mirzaian
,et al.Firouznia K, Ghanaati H, Alavian SM, Azadeh P, Nasiri Toosi M, et al. Transcatheter Arterial Chemoembolization Therapy for Patients With Unresectable Hepatocellular Carcinoma. Hepat Mon. 2014;14(12):e25792. doi: https://doi.org/10.5812/hepatmon.25792
Comments
Number of Comments:0Cited by
- Scopus by DOI: 0
Last Update: 2 weeks ago
- Scopus by Title: 4
Last Update: 2 weeks ago
- Scopus by Title (Ref): 0
Last Update: 2 weeks ago
- CrossRef: 0
Last Update: 2 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Search Relations
Author(s):
Related Articles